e-learning
resources
Amsterdam 2011
Tuesday, 27.09.2011
Clinical perspectives in several interstitial diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Quadriceps function is reduced in fibrotic idiopathic interstitial pneumonia
L. Mendoza, A. Gogali, S. Kemp, D. Shrikrishna, A. Jackson, G. Cavada, M. Polkey, A. Wells, N. Hopkinson (Santiago, Chile; Ioannina, Greece; London, United Kingdom)
Source:
Annual Congress 2011 - Clinical perspectives in several interstitial diseases
Session:
Clinical perspectives in several interstitial diseases
Session type:
Thematic Poster Session
Number:
3757
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Mendoza, A. Gogali, S. Kemp, D. Shrikrishna, A. Jackson, G. Cavada, M. Polkey, A. Wells, N. Hopkinson (Santiago, Chile; Ioannina, Greece; London, United Kingdom). Quadriceps function is reduced in fibrotic idiopathic interstitial pneumonia. Eur Respir J 2011; 38: Suppl. 55, 3757
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Optimizing invasive ventilation for SMA type 1 children who are receiving the gene therapy
Related content which might interest you:
The classification, natural history and radiological/histological appearance of idiopathic pulmonary fibrosis and the other idiopathic interstitial pneumonias
Source: Eur Respir Rev 2008; 17: 108-115
Year: 2008
Acute exacerbation of idiopathic pulmonary fibrosis as the initial presentation of the disease
Source: Eur Respir Rev 2009; 18: 129-132
Year: 2009
Clinical features of usual interstitial pneumonia-correlation between idiopathic pulmonary fibrosis and connective tissue disease associated with usual interstitial pneumonia
Source: International Congress 2016 – Connective tissue disorders
Year: 2016
Histology and pathogenesis of usual interstitial pneumonia (UIP)
versus
nonspecific interstitial pneumonia (NSIP): progressive remodeling or resolution and healing?
Source: Annual Congress 2006 - Usual interstitial pneumonia (UIP) and nonspecific interstitial pneumonia (NSIP), idiopathic or not: new concepts in diagnosis and treatment
Year: 2006
Idiopathic pulmonary fibrosis - IPF
Source: Respipedia Article
Year: 2018
Markers of fibrosis and tissue destruction in usual interstitial pneumonia associated with pulmonary emphysema
Source: Eur Respir J 2007; 30: Suppl. 51, 489s
Year: 2007
Idiopathic pulmonary fibrosis (IPF) and idiopathic nonspecific interstitial pneumonia (NSIP): what treatment and for whom?
Source: Annual Congress 2006 - Usual interstitial pneumonia (UIP) and nonspecific interstitial pneumonia (NSIP), idiopathic or not: new concepts in diagnosis and treatment
Year: 2006
Analysis of small airway function in patients with idiopathic interstitial pneumonia
Source: Annual Congress 2008 - Clinical aspects of interstitial lung disease
Year: 2008
Survival of patients with biopsy-proven usual interstitial pneumonia and nonspecific interstitial pneumonia
Source: Eur Respir J 2002; 19: 1114-1118
Year: 2002
Cryptogenic fibrosing alveolitis/idiopathic pulmonary fibrosis
Source: Eur Respir J 2001; 18: 43S-55S
Year: 2001
Inhibition of local fibrinolysis differs between idiopathic pulmonary fibrosis (IPF) and fibrotic non-specific interstitial pneumonia (f-NSIP)
Source: Annual Congress 2009 - Idiopathic pulmonary fibrosis: concepts and mechanisms
Year: 2009
Significance of connective tissue disease features in idiopathic interstitial pneumonia
Source: Eur Respir J 2012; 39: 661-668
Year: 2012
Changes in the small airways in idiopathic pulmonary fibrosis
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities
Year: 2013
Clinical significance of histological classification of idiopathic interstitial pneumonia
Source: Eur Respir J 2002; 19: 275-283
Year: 2002
Lymphatic fluctuation in parenchymal remodelling stage of organising pneumonia, nonspecific interstitial pneumonia and idiopathic pulmonary fibrosis
Source: Annual Congress 2009 - Various backgrounds in diffuse parenchymal lung disease
Year: 2009
Comparison between patients with idiopathic pulmonary fibrosis and patients with pulmonary involvement of the usual interstitial pneumonia pattern that preceded the onset of rheumatoid arthritis
Source: International Congress 2014 – ILDs: connective tissue disease
Year: 2014
Immunogenetic background of children´s idiopathic interstitial pneumonias and adult idiopathic pulmonary fibrosis
Source: Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease
Year: 2010
Clinical efficacy of pirfenidone in patients with severe fibrosing interstitial pneumonia
Source: International Congress 2015 – Treatment of IPF
Year: 2015
Increased levels of oxidative stress markers in patients with idiopathic pulmonary fibrosis
Source: International Congress 2016 – Common mechanisms in lung development and fibrosis
Year: 2016
Interstitial lung abnormalities with a diagnosis of idiopathic pulmonary fibrosis
Source: Virtual Congress 2021 – Translational and other aspects of idiopathic interstitial pneumonia
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept